These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4610196)

  • 41. The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures.
    Rathlev NK; D'Onofrio G; Fish SS; Harrison PM; Bernstein E; Hossack RW; Pickens L
    Ann Emerg Med; 1994 Mar; 23(3):513-8. PubMed ID: 8135426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Studies of the effect of 5,5-diphenylhydantoin on the bioelectric activity of the brain in epilepsy].
    Domzal T; Gajkowski K
    Neurol Neurochir Pol; 1971; 5(3):301-6. PubMed ID: 5000628
    [No Abstract]   [Full Text] [Related]  

  • 43. Thioridazine HC1 Vs. chlordiazepoxide HC1 in controlling symptoms attributable to alcohol withdrawal.
    Pena-Ramos A
    Dis Nerv Syst; 1977 Mar; 38(3):143-7. PubMed ID: 837817
    [No Abstract]   [Full Text] [Related]  

  • 44. COMPARATIVE CLINICAL EVALUATION OF CHLORDIAZEPOXIDE AND PROMAZINE IN TREATMENT OF ALCOHOL-WITHDRAWAL SYNDROME.
    SERENY G; KALANT H
    Br Med J; 1965 Jan; 1(5427):92-7. PubMed ID: 14218487
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of ventricular ectopic rhythms with diphenylhydantoin.
    Kemp GL
    J Am Geriatr Soc; 1972 Jun; 20(6):265-7. PubMed ID: 4555667
    [No Abstract]   [Full Text] [Related]  

  • 46. The ineffectiveness of diphenylhydantoin in preventing febrile convulsions in the age of greatest risk, under three years.
    Melchior JC; Buchthal F; Lennox-Buchthal M
    Epilepsia; 1971 Mar; 12(1):55-62. PubMed ID: 4996854
    [No Abstract]   [Full Text] [Related]  

  • 47. Single daily dose of diphenylhydantoin in children.
    Buchanan RA; Turner JL; Moyer CE; Heffelfinger JC
    J Pediatr; 1973 Sep; 83(3):479-83. PubMed ID: 4725154
    [No Abstract]   [Full Text] [Related]  

  • 48. Metronidazole in the treatment of alcoholism. A clinical trial and review of the literature.
    Lal S
    Q J Stud Alcohol; 1969 Mar; 30(1):140-51. PubMed ID: 4887733
    [No Abstract]   [Full Text] [Related]  

  • 49. [Tiapride and alcohol withdrawal].
    Parent M; Jadot M; Toussaint C
    Rev Med Liege; 1978 Oct; 33(19):672-7. PubMed ID: 30160
    [No Abstract]   [Full Text] [Related]  

  • 50. [Changed phenytoin kinetics in chronic alcoholism].
    Beier R; Zschiesche M
    Psychiatr Neurol Med Psychol (Leipz); 1982 Oct; 34(10):597-601. PubMed ID: 7163421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lorazepam for the prevention of recurrent seizures related to alcohol.
    Matz R
    N Engl J Med; 1999 Aug; 341(8):609-10. PubMed ID: 10475809
    [No Abstract]   [Full Text] [Related]  

  • 52. A controlled replication of the effectiveness of diphenylhydantoin in reducing irritability and anxiety in selected neurotic outpatients.
    Stephens JH; Shaffer JW
    J Clin Pharmacol; 1973; 13(8):351-6. PubMed ID: 4579971
    [No Abstract]   [Full Text] [Related]  

  • 53. [Beta blocker treatment in alcohol withdrawal. A double-blind test with pindolol (Viskén)/placebo].
    Digranes O
    Tidsskr Nor Laegeforen; 1976 Feb; 96(4):226-8. PubMed ID: 766297
    [No Abstract]   [Full Text] [Related]  

  • 54. [5,5-Diphenylhydantoin (hydantoinal Polfa)].
    Pakszys W
    Neurol Neurochir Pol; 1973; 7(1):79-84. PubMed ID: 4570505
    [No Abstract]   [Full Text] [Related]  

  • 55. One daily dose of diphenylhydantoin (DPH) to patients with epilepsy.
    Strandjord RE; Johannessen SI
    Acta Neurol Scand Suppl; 1972; 51():499-500. PubMed ID: 4514392
    [No Abstract]   [Full Text] [Related]  

  • 56. Diphenylhydantoin effectiveness in the treatment of chronic schizophrenics. A double-blind controlled study with a placebo.
    Simopoulos AM; Pinto A; Uhlenhuth EH; McGee JJ; DeRosa ER
    Arch Gen Psychiatry; 1974 Jan; 30(1):106-11. PubMed ID: 4587066
    [No Abstract]   [Full Text] [Related]  

  • 57. [The use of medicinal glycerin in treating alcoholics].
    Sosin IK; Gurevich IaL; Mys'ko GN; Tochilovskiĭ AS; Bozhko GKh
    Vrach Delo; 1990 May; (5):83-5. PubMed ID: 2396406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug treatment of anxiety and depression in detoxified alcoholic patients.
    Overall JE; Brown D; Williams JD; Neill LT
    Arch Gen Psychiatry; 1973 Aug; 29(2):218-25. PubMed ID: 4741512
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of diphenylhydantoin on anxiety and hostility in institutionalized prisoners.
    Gottschalk LA; Covi L; Uliana R; Bates DE
    Compr Psychiatry; 1973; 14(6):503-11. PubMed ID: 4587507
    [No Abstract]   [Full Text] [Related]  

  • 60. A method for shifting from oral to intramuscular diphenylhydantoin administration.
    Wilder BJ; Serrano EE; Ramsey E; Buchanan RA
    Clin Pharmacol Ther; 1974 Sep; 16(3):507-13. PubMed ID: 4411662
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.